DB

Diem Bioventures

Description

Diem Bioventures

Investor Profile

Diem Bioventures has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series Unknown (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Diem Bioventures frequently co-invest with?

Elm Street Ventures
North America, Connecticut, United States, New Haven
Co-Investments: 1
HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 1
CA
North America, Massachusetts, United States, Boston
Co-Investments: 1
HBM Partners
Europe, Zug, Switzerland, Zug
Co-Investments: 1
Lundbeckfonden Ventures
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 1
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 1
Georgia Venture Partners
North America, Georgia, United States, Atlanta
Co-Investments: 1
ATDC
North America, Georgia, United States, Atlanta
Co-Investments: 1
H.I.G. BioHealth Partners
North America, Florida, United States, Miami
Co-Investments: 1
JLABS
North America, California, United States, San Diego
Co-Investments: 1

What are some of recent deals done by Diem Bioventures?

Iconic Therapeutics

South San Francisco, California, United States

Iconic Therapeutics develops and commercializes immunoconjugate proteins that trigger the immune system to destroy invader cells.

BiopharmaBiotechnologyTherapeutics
Series UnknownJun 15, 2018
Amount Raised: $4,110,000